More than two-thirds of patients reported pain or required analgesics. Of those, 670 were given inadequate analgesic prescribing, the study found. In addition, 19.3 percent reported moderate or severe pain and 40 percent of those patients did not receive an opioid analgesic. Physicians prescribed strong opioids for 13.4 percent of patients.
The prospective and observational study of pain and analgesic prescribing covered medical oncology outpatients with breast, colorectal, lung or prostate cancer.
Read the HemOnc Today report on treatment of pain.
Related Articles on Treatment of Pain:
Army Grants $5.6M to Research Sublingual Opioid for Pain
Study: Treating Low Back Pain Reverses Brain Decline Caused by Pain
5 Pain Programs Recognized for Excellence by American Pain Society
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.